Abstract

The objective of this contract is to undertake performance of a clinical trial to assess the safety and efficacy of an investigational antiepileptic compound, remacemide, in patients with partial seizures. The Contractor will study 20 patients over a 15 month period.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research and Development Contracts (N01)
Project #
N01NS072312-002006
Application #
3670894
Study Section
Project Start
1991-04-15
Project End
1993-12-31
Budget Start
1993-02-09
Budget End
1993-12-31
Support Year
Fiscal Year
1993
Total Cost
Indirect Cost

  Institution

Name
University of Alabama Birmingham
Department
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294